Tech Company Financing Transactions
Kardium Funding Round
Kardium closed a $104 million investment round on 6/12/2024. Investors included Fidelity Management & Research Company, Durable Capital Partners and T. Rowe Price.
Transaction Overview
Company Name
Announced On
6/12/2024
Transaction Type
Venture Equity
Amount
$104,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to complete its PULSAR clinical study in order to obtain regulatory approvals for the Globe System, to grow the manufacturing team and capacity, and to build a clinical support and commercial team in preparation for the commercial launch of the Globe System.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8518 Glenlyon Pkwy. 155
Burnaby BC, V5J 0B6
Canada
Burnaby BC, V5J 0B6
Canada
Phone
Website
Email Address
Overview
Kardium Inc. is a rapidly growing medical solutions company that has developed an advanced system for the treatment of atrial fibrillation (AF), which affects more than 37 million people worldwide.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Amos Michelson
Chief Executive Officer
Kevin Chaplin
President
Douglas Goertzen
Browse more venture capital transactions:
Prev: 6/12/2024: Layer3 venture capital transaction
Next: 6/12/2024: Arya venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs